NASDAQ:CUE - Cue Biopharma, Inc.
$6.33
 $0.22
+3.52%
2:35PM EDT
2019-02-15
Cue Biopharma Inc, incorporated on December 31, 2014, is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes MHC Class I Program, and MHC Class II Program. The CUE-100 Framework restricts the activity of T cell populations. The CUE-200 Framework enables potent, long-lived anti-tumor T cell responses. The Autoimmune disease therapy protects the healthy cells from immune attack.Immuno-Oncology CUE-100 FrameworkThe CUE-100 Framework restricts the activity of T cell populations. The lead component of CUE-100 Framework is CUE-101 a fusion variant of cytokine Interleukin-2. It treats the unmet clinical needs like human papilloma virus driven cancers. Immuno-Oncology CUE-200 FrameworkThe CUE-200 Framework is designed to enable potent, long-lived T cell responses against the tumor cells that evade the immune system. It aims at stimulating and activating the naive T cells for anti-tumor responsesAutoimmune DiseaseThe Autoimmune disease therapy protects the healthy cells from immune attack by modulating the immune system. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CUE     avg for
industry  
  avg for
sector  
42 stocks weight:  35. 33   0. 00   0. 00  
42 stocks rank:  3. 16 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  

quick ratio:  8. 54   5. 37   1. 81  
current ratio:  8. 86   5. 69   2. 19  

target price low:  14. 50   88. 97   117. 82  
target price avg:  14. 50   115. 19   141. 96  
target price high:  14. 50   143. 40   163. 16  
1-yr high:  17. 25   124. 30   142. 77  
last close:  6. 11   101. 85   127. 84  
50-day avg:  5. 27   98. 27   122. 46  
200-day avg:  8. 63   99. 72   122. 70  
1-yr low:  4. 35   78. 19   100. 16  
volume:  132. 55 K 2. 38 M 4. 64 M
50-day avg volume:  102. 36 K 3. 31 M 4. 94 M
200-day avg volume:  97. 36 K 3. 23 M 4. 28 M

1-day return:  1. 83 % 0. 22 % 0. 48 %
this week return:  12. 52 % 1. 77 % 2. 01 %
12-wk return:  14. 42 % 6. 56 % 3. 33 %
52-wk return:  -63. 28 % -2. 23 % 14. 35 %

enterprise value (EV):  66. 92 M 55. 17 B 104. 51 B
market cap:  126. 46 M 49. 01 B 96. 46 B
EBITDA:  -37. 49 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 78   -91. 79   2. 29  
enterprise/revenue (EV/R):  82. 42   29. 84   23. 39  
total revenue:  812. 00 K 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -37. 80 M 2. 37 B 3. 58 B

shares outstanding:  20. 70 M 607. 99 M 1. 22 B
shares:  15. 27 M 605. 53 M 1. 15 B
shares short:  1. 13 M 11. 62 M 12. 55 M
shares short prior month:  1. 24 M 11. 95 M 13. 44 M
short ratio:  11. 64   4. 82   3. 10  
short % of float:  6. 47 % 6. 19 % 2. 82 %
total cash/share:  1. 95   12. 02   11. 46  
total cash:  39. 18 M 7. 41 B 7. 37 B
free cash flow:  -17. 07 M 95. 99 M 2. 04 B
operating cash flow:  -24. 41 M 164. 74 M 3. 04 B

book value:  1. 96   14. 43   28. 26  
price/book:  3. 12   -1. 57   -2. 97  
operating margins:  -4700. 60 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  15. 53 % --- ---
1-yr mean volatility:  -0. 25 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 12   3. 03   4. 09  
forward EPS:  -1. 63   4. 33   6. 99  
P/E:  -2. 88   6. 11   26. 91  
forward P/E:  -3. 68   8. 38   10. 48  
PE/G:  0. 14   0. 37   5. 61  
growth:  -20. 37 % 683. 72 % 104. 79 %
earnings high:  -0. 40   1. 27   1. 66  
earnings avg:  -0. 40   1. 01   1. 53  
earnings low:  -0. 40   0. 76   1. 40  
revenue high:  230. 00 K 2. 86 B 11. 19 B
revenue avg:  230. 00 K 2. 78 B 10. 84 B
revenue low:  230. 00 K 2. 67 B 10. 64 B
return on assets:  -93. 78 % -3. 27 % 3. 81 %
return on equity:  -172. 65 % 107. 48 % 27. 82 %
revenue/share:  0. 05   14. 68   59. 83  

beta (1yr vs S&P500):  0. 55   1. 21   0. 93  
sharpe (1yr):  -0. 91   0. 06   0. 98  

held % insiders:  21. 00 % 6. 46 % 3. 21 %
held % institutions:  22. 19 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : CUE
.    + 0.353 =         0.353 :: INITIAL WEIGHT
.  + 504.823 =       505.176 :: inverse volume-to-price addition
.  + 290.558 =       795.734 :: spline projection addition
.  - 175.926 =       619.809 :: poor performance penalty
.    x 0.656 =       406.841 :: one-year gains+dividend factor
.    x 6.461 =      2628.747 :: 13 weeks' performance factor
.    x 1.492 =      3923.375 :: industry recommendation factor
.    x 1.762 =      6914.052 :: EV/R factor
.    x 0.991 =      6849.214 :: return on assets factor
.    x 0.983 =      6730.961 :: return on equity factor
.    x 2.444 =     16453.054 :: current ratio factor
.    x 1.064 =     17509.467 :: quick ratio factor
.    x 1.042 =     18246.097 :: short ratio factor
.    x 2.031 =      37061.86 :: price-to-book factor
.    x 1.062 =     39372.779 :: 5-day avg > 50-day avg
.    x 2.159 =      84992.09 :: P/E weight
.     x 1.63 =    138569.902 :: PE/G factor
.     x 1.46 =    202354.772 :: beta factor
.    x 0.912 =    184524.698 :: sharpe factor
.    x 2.343 =    432266.605 :: target low factor
.    x 1.391 =    601112.617 :: target mean factor
.    x 1.117 =    671552.109 :: target high factor
.    x 1.066 =    715614.528 :: industry 12-weeks return
.    x 0.891 =     637481.33 :: "drift" penalty 1 days ago
.    x 0.908 =    578588.169 :: "drift" penalty 4 days ago
.    x 0.999 =    577997.069 :: overall "drift" factor
.    x 0.845 =    488223.056 :: largest single-day jump factor
.     x 0.09 =     44103.257 :: low price factor
.      x 1.0 =     44106.217 :: factor hist industry gain for week 06
.   cubeRoot =        35.332 :: reduced for readability
.                     35.332 :: FINAL WEIGHT for NASDAQ:CUE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org